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Toxin-antitoxin (TA) systems are found on both bacterial plasmids
and chromosomes, but in most cases their functional role is un-
clear. Gene knockouts often yield limited insights into functions of
individual TA systems because of their redundancy. The well-char-
acterized F-plasmid–based CcdAB TA system is important for
F-plasmid maintenance. We have isolated several point mutants
of the toxin CcdB that fail to bind to its cellular target, DNA gyrase,
but retain binding to the antitoxin, CcdA. Expression of such mu-
tants is shown to result in release of theWT toxin from a functional
preexisting TA complex as well as derepression of the TA operon.
One such inactive, active-site mutant of CcdB was used to demon-
strate the contribution of CcdB to antibiotic persistence. Transient
activation of WT CcdB either by coexpression of the mutant or by
antibiotic/heat stress was shown to enhance the generation of
drug-tolerant persisters in a process dependent on Lon protease
and RecA. An F-plasmid containing a ccd locus can, therefore, func-
tion as a transmissible persistence factor.
CcdA-CcdB | conditional regulation | protein—protein interaction
Many bacterial genomes harbor a class of genes referred toas toxin-antitoxin (TA) genes. These genes were initially
discovered on low copy-number plasmids of Escherichia coli and
appear to be involved in plasmid maintenance in the bacterial
population (1). TA systems comprise of a pair of genes organized
in an operon encoding a stable toxin and a labile antitoxin that
antagonizes it (1). Plasmid-based TA systems are also known as
addiction modules and selectively eliminate daughter cells that
do not inherit a plasmid copy during cell division (1). This mech-
anism, also called postsegregational killing, occurs in daughter
cells devoid of a plasmid copy. The unstable antitoxin counter-
part is degraded more rapidly by host proteases than the toxin.
The toxin is released from the TA complex and interacts with an
essential host target. This interaction often results in cell death
but in some cases, as shown below, may also result in growth
inhibition (2).
Homologs of plasmid-based TA systems have recently been
discovered on the chromosomes of a large number of bacteria,
many of which are pathogenic (3). The biological role of these TA
systems in bacteria still remains controversial. A number of dif-
ferent models have been proposed to explain their presence on the
chromosome (4). TA systems are difficult to study because over-
expression of the active toxin component typically leads to cell
death. Because many bacteria contain multiple homologous TA
systems with redundant functions, multiple TA systems may need
to be knocked out before there is an observable phenotype (5). In
the present work, we describe a methodology to conditionally
regulate expression of a toxin gene in a dose-dependent fashion.
The method involves the release of the WT toxin from the TA
complex by an overproduced mutant toxin that has a high affinity
for the antitoxin but a low affinity for the cellular target of WT
toxin (Fig. S1). This approach was validated using the well-estab-
lished plasmid-based CcdAB TA system and used to demonstrate
that this system plays a role in bacterial persistence. Bacterial
persistence is a phenotype of dormant cells present at a low
frequency in a growing population and characterized by tolerance
to the presence of a variety of antibiotics, even in the absence of an
active, specific resistance mechanism. Persisters are likely to be
clinically important (6, 7). In the present work, we show that the
F-plasmid derived ccd operon, whether located on a multicopy
plasmid or in a single copy on the E. coli chromosome, plays
a significant role in the generation of persisters. This finding is in
addition to its well-studied role in plasmid maintenance (8). The
methodology described here may also be used to probe the role of
specific TA systems in other organisms where making knockouts
are difficult or which have multiple homologous TA systems.
Results
Inactive, Active-Site Mutants of CcdB. CcdAB is one of the most
well-studied plasmid-based TA systems and is involved in
maintenance of F-plasmid in E. coli (8). CcdB is a DNA gyrase
poison that entraps a cleavage complex between gyrase and
DNA (9). In the presence of its antagonist, CcdA, CcdB is se-
questered in the form of a CcdAB complex. However, if the cell
loses the F-plasmid, the labile CcdA is degraded by the ATP-
dependent Lon protease (2), releasing CcdB from the complex
to act on its target DNA gyrase, which eventually leads to cell
death. The crystal structure of CcdB in complex with a fragment
of DNA gyrase has been determined. The active-site residues of
CcdB are defined as those that are involved in direct interaction
with DNA gyrase, as determined by Ala and Asp scanning mu-
tagenesis (10) and confirmed by X-ray crystallography of the
CcdB:GyrA14 fragment complex (11). These comprise residues
Ile24, Ile25, Asn95, Phe98, Trp99, and Ile101 (Fig. 1A). We have
previously reported the construction and phenotypic character-
ization of a large library comprising of a total of 1,430 (75%) of
the 1,900 possible single-site mutants of CcdB (12). The mutants
were expressed under control of the arabinose inducible PBAD
promoter in pBAD24ccdB (13). In this system, the level of ex-
pression of each mutant can be modulated by varying the arab-
inose concentration in the medium.
No structure was available for the CcdA:CcdB complex when
this work was initiated. However, we hypothesized that there
should be CcdB mutants that affect binding to DNA gyrase but
not CcdA. Such mutants should be nontoxic when overexpressed
in a CcdB-sensitive E. coli strain that lacks WT CcdB. However,
when overexpressed in F-plasmid containing strains that express
WT CcdB and its antitoxin CcdA, such mutants should cause cell
death by titrating out CcdA, thereby permitting WT CcdB to
bind to its cellular target. To validate this hypothesis, 10 inactive
mutants previously isolated (12) at active-site residues involved
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in DNA gyrase binding were characterized. In initial experi-
ments, mutants were overexpressed in two different E. coli
strains, one containing an F-plasmid encoding WT CcdB and the
other lacking the F-plasmid. The resulting phenotypes were
characterized. The E. coli strains used were: Top10, which lacks
the F-plasmid (and hence CcdA and CcdB), and either XL1-Blue
or Top10F′, both of which carry the F-plasmid containing the ccd
operon. The selected mutants (Table S1), when overexpressed in
the Top10 strain with saturating inducer concentration (0.1%
arabinose), showed an inactive phenotype. This finding demon-
strates that in contrast to WT CcdB, these mutants lack the ability
to bind and poison the DNA gyrase, and thus to cause cell death.
When the same inactive CcdB mutants were overexpressed in
either Top10F′ or XL1-Blue, 7 of the 10 showed complete ab-
sence of colonies (Fig. S2), comparable to the phenotype ob-
served with overexpression of WT CcdB. This finding indicated
that most inactive, active-site mutants of CcdB, when overex-
pressed, were able to titrate out WT CcdA from the WT CcdA-
CcdB complex. The released WT CcdB likely caused cell death by
binding to its cellular target, DNA gyrase. Although Top10F′ and
XL1-Blue are recA−, similar results were obtained in the recA
containing E. coli strain AB264. As a negative control, several
inactive, buried-site mutants (Table S1) were also overexpressed
in both Top10 and Top10F′ strains. These buried-site mutants are
expected to have a distorted, destabilized, and aggregation-prone
structure and thus are not expected to be able to release WT
CcdB from the CcdAB complex. As expected, cells expressing
these mutants did not show any growth defects and showed
growth comparable to cells overexpressing the thioredoxin control
protein, in both strains.
WT CcdB Causes Growth Arrest When Expressed at Low Levels. To
examine whether lower amounts of free WT CcdB cause re-
versible growth arrest or cell death in our system, Top10F′ and
AB264 strains were transformed with inactive, active-site mutants
and plated on LB/amp plates containing variable amounts of
arabinose. Normal growth was observed in the range 0% to 1 ×
10−4% arabinose. From 1 × 10−3 to 2 × 10−2% arabinose, colony
size became progressively smaller, although the number of col-
onies was unchanged and at higher arabinose concentrations (1 ×
10−1% and higher) no colonies were observed. To examine if the
growth inhibition at low arabinose concentrations was reversible,
the strain carrying F-plasmid was transformed with the inactive,
active-site mutant 100TCcdB and grown in liquid culture. Log-
phase cells (OD600 = 0.2) were induced with varying concen-
trations of arabinose for 2 h and plated on LB/amp plates con-
taining 0.2% glucose to repress further expression of 100TCcdB
from the PBAD promoter. It was found that cells induced with up
to 0.01% arabinose showed reversible growth inhibition, but at
higher arabinose concentrations there was significant cell death
(Fig. S3). This finding demonstrates that exposure of cells to low
levels of WT CcdB causes reversible growth inhibition but higher
levels cause cell death.
In Vitro Studies of CcdB Mutants Binding to DNA Gyrase and CcdA. To
confirm that the inactive, active-site mutants of CcdB still bind
CcdA but have diminished affinity for gyrase, four such mutants
(24K, 24M, 95P, 100T) were purified and characterized by sur-
face plasmon resonance (SPR). Purified GyrA14 (residues 363–
494) or CcdA was immobilized on the surface of a CM5 chip.
WT CcdB and all mutants were passed over the chip surface.
Values of the measured parameters are summarized in Table S2.
The data show that the mutants bind 5- to 50-fold more weakly
to GyrA than WT CcdB, but bind CcdA with similar or higher
affinity than WT CcdB.
Expression of Inactive, Active-Site Mutant Leads to Derepression of
the ccd Promoter. The phenotypic effects observed on over-
expression of the inactive, active-site mutants in the presence of
WT CcdAB could arise through two different mechanisms. The
inactive mutant could displace WT CcdB from its complex with
CcdA either directly or by binding to free CcdA. In the latter
case, the consequent decrease in free CcdA would lead to dis-
sociation of WT CcdB from its complex with CcdA to maintain
equilibrium. In either event, the free WT CcdB could then bind
to its cellular target, DNA gyrase, resulting in growth inhibition
or cell death. Alternatively (or in addition), an increase in the
CcdB:CcdA ratio as a result of mutant expression could lead to
derepression of the ccd operon and fresh synthesis of CcdA and
WT CcdB (14). The fresh CcdA would bind to the excess, in-
active mutant of CcdB and the newly synthesized CcdB could
bind to its cellular target, DNA gyrase. To determine whether
expression of an inactive, active-site mutant of CcdB results in
derepression of the ccd operon, two different approaches were
used. In the first approach, the ability of excess 100TCcdB to
decrease binding of WT CcdAB complex to promoter DNA was
studied by SPR (Fig. S4) and EMSA (Fig. 2). In both cases, it was
observed that DNA binding of the CcdAB complex was de-
creased in the presence of excess 100TCcdB, as described pre-
viously for WT CcdB (14). It can also be seen that the complex of
Fig. 1. Interacting residues on CcdB. (A) CcdB2 structure (green) showing
residues interacting with GyrA142 and CcdA2 in blue and red, respectively.
Violet spheres correspond to residues which bind both to CcdA and GyrA14.
Cyan spheres indicate Gyrase interacting residues, which are proximal (but
not overlapping) to CcdA interacting residues (red). Residue numbers are
shown adjacent to each sphere. (B) Overlap of CcdA and GyrA14 binding sites
on CcdB. Model was generated by superposing CcdB2 (green) from complexes
with GyrA142 [PDB ID 1X75, blue (11)] and CcdA2 [PDB ID 3G7Z, red (22)],
respectively. This figure was created using PyMOL (http://www.pymol.org).
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100TCcdB with CcdA (lanes 6–8, Fig. 2) binds ccdP/O DNA,
although less well than the WT CcdB:CcdA complex. This
finding is consistent with an earlier study (15) that showed that
100R and 100E CcdB mutants led to loss of toxin activity but
retained the ability to bind the operator when complexed to
CcdA. In an alternate approach, a GFP reporter was fused to the
ccd promoter and cloned to yield the plasmid pccdP/O-gfp with
a p15A origin. The effect of expression of the inactive mutant,
100TCcdB on GFP expression was monitored in both Top10F′
and Top10 strains. As can be seen in Fig. S5A, the ratio of GFP
expression in induced to uninduced cells was appreciably higher
for Top10F′ strain. This finding suggests that overexpression of
100TCcdB leads to derepression of the ccd operon by reducing
the CcdA:CcdB ratio, resulting in fresh synthesis of WT CcdB.
Overexpression Studies with 100TCcdB Suggest a Possible Role of
CcdB in Generation of Persisters. Plasmids expressing WT CcdB
under control of the PBAD promoter are toxic to E. coli, even
under highly repressed conditions (0.2% glucose) (12). However,
expression of low levels of an inactive, active-site mutant (such as
100TCcdB) in cells containing the WT ccd operon, by the ad-
dition of 0.001% arabinose results in growth inhibition. Under
these conditions, we examined the effects of the antibiotics
ciprofloxacin, mitomycin C, cefotaxime, kanamycin, and tobra-
mycin on cell viability. For this process, AB264/p100TccdB cells
induced for 100TCcdB expression for 1 h were subsequently
exposed to lethal doses of different drugs (ciprofloxacin, mito-
mycin C, cefotaxime, kanamycin, tobramycin) for 4 h. Cells were
then washed, plated on 0.2% glucose containing medium to re-
press further expression of 100TCcdB, and the surviving colonies
were counted. In comparison with the uninduced cells, induced
cells showed ∼850-, 750-, and 350-fold more tolerance to cip-
rofloxacin, mitomycin C and cefotaxime, respectively, as well
250- and 150-fold increased tolerance against kanamycin and
tobramycin, respectively (Fig. 3). Compared with cells lacking
the 100TCcdB plasmid, levels of tolerance were even higher (Fig.
S6). To rule out the possibility of development of antibiotic re-
sistance because of mutation during the course of the experi-
ment, persister-derived colonies were replica plated on LB plates
containing antibiotics or without any antibiotic. Bacterial growth
was found only in the absence of any antibiotic. This finding
confirms the generation of true persisters at low levels of CcdB
expression. These data show that in addition to its well-studied
role in plasmid maintenance, the CcdAB system may also be
involved in the generation of persisters.
CcdB-Induced Persister Formation Is Dependent on RecA and Lon
Protease. Poisoning of Gyrase:DNA complexes by CcdB in vivo,
results in induction of a RecA mediated SOS response (16). The
SOS response has previously been linked to persister formation
via enhanced expression of TisB (17). To study the role of RecA
on CcdB mediated persister formation, 100TCcdB was expressed
in AB264 deleted for recA. Relative to the WT strain under
identical conditions, the survival was over 100-fold reduced in
the presence of ciprofloxacin and mitomycin C, respectively, and
smaller reductions in survival were observed for the other anti-
biotics (Fig. 3). The involvement of RecA in DNA repair (18)
explains why recA deletion makes bacteria particularly sensitive
toward antibiotics that target DNA either directly (mitomycin C)
or indirectly (ciprofloxacin).
Overexpression of inactive 100TCcdB results in an increase in
the level of free WTCcdB, because of titration of any CcdA that is
present as well as fresh synthesis of WTCcdB. The protease Lon is
involved in degradation of freeCcdA as well as activation of various
genes during stress (19). In the present case, there should be little
free CcdA present because of the presence of excess, inactive
100TCcdB. Nevertheless, to investigate the possible role of Lon in
CcdB-mediated persister formation, the antibiotic sensitivity was
examined in the presence and absence of overexpressed 100TCcdB
in E. coli strain AB264:Δlon/p100TccdB, as described above. De-
letion of lon led to about a 10-fold decrease in percentage survival
relative to the WT strain and 50- to 200-fold decrease in survival
ratio relative to the corresponding uninduced control (Fig. 3). This
result clearly demonstrates that Lon also plays an important role in
CcdB-mediated persister generation, apart from its role in antitoxin
degradation (2, 5). Because both Lon and RecA are involved in
CcdB-mediated persister generation, the above experiments were
repeated in the AB264ΔlonΔrec double-knockout. In the double-
knockout, persisters were further reduced to close to background
levels, suggesting that the downstream pathways activated by Lon
and RecA to generate persisters are at least partially independent.
Further Confirmation of CcdB’s Role in Persistence. The above studies
involving overexpression of 100TCcdB suggested a possible role
for the ccd operon in the generation of persisters. Use of an in-
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Fig. 2. Binding of CcdA-WTCcdB and CcdA-100TCcdB complex to ccdP/O
monitored by EMSA. A radiolabeled DNA fragment containing the ccdP/O
was incubated with increasing concentrations of CcdA-WTCcdB (lanes 1–5) or
CcdA-100TCcdB complex (lanes 6–8) at a CcdA:CcdB ratio of 1.5:1. The data
show that CcdA-100TCcdB complex binds less well to DNA than CcdA-WTCcdB
(lanes 5 and 8) and also that addition of 100TCcdB to the preformed CcdA-
WTCcdB complex, results in a decrease in the amount of DNA binding (lanes
9–11), presumably because of a decrease in the overall CcdA:CcdB ratio.
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Fig. 3. Effect of Lon and RecA on CcdB mediated persister generation.
AB264 (WT), AB264Δrec, AB264Δlon, and AB264ΔlonΔrec strains were in-
duced for the expression of 100TCcdB mutant protein for 1 h at an OD600 of
0.2. Subsequently, the cells were challenged with different antibiotics at ∼10
times minimal inhibitory concentration for 4 h. Percent survival was calculated
as the ratio (cfu after antibiotic exposure/cfu before antibiotic exposure) ×
100. Survival ratio is defined as the ratio of percent survival of the E. coli strain
induced for 100TCcdB to the corresponding uninduced strain. (A) The percent
survival of the induced cells; (B) the survival ratio. Both values are shown in
log scale. Error bars indicate the SE from three independent experiments.
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active, active-site mutant, such as 100TCcdB, provides a powerful
tool to conditionally regulate expression from theWT ccd operon.
However, the WT CcdB levels generated using this system may
not be physiologically relevant. Expression of the ccd operon is
known to be triggered by various stresses, including heat (2, 20).
We therefore compared the survival of cells with and without the
ccd operon. Cells were first exposed to either heat or a sublethal
dose of antibiotic prestress (21) (to derepress the operon) (Fig.
S5B) followed by exposure to lethal concentrations of various
different antibiotics (Fig. 4). Three different formats were used,
namely: (i) Top10 cells containing F-plasmid, present at one to
two copies, each molecule of plasmid contains one copy of the ccd
operon but numerous other genes as well; (ii) Top10 cells
transformed with the small multicopy pccd plasmid (10–12 copies
per cell); and (iii) cells in which the ccd operon was integrated in
single copy into the chromosome of the E. coli strain BW25113
(see SI Materials and Methods). This process was done not to
simulate chromosomal ccd systems, but rather to quantitate the
role of the F-plasmidic ccd operon in single copy on persister
formation, in the absence of other F-plasmid genes. In each case,
the number of persister cells were compared with the relevant
control strain lacking the ccd operon (Fig. 4). In all cases, there
was a significant increase in survival for cells containing the ccd
operon, although the effects were not as large as those seen upon
continuous expression of the inactive, active-site mutant (Fig. 3).
This result is presumably because of lower activation of the ccd
operon by transient heat or antibiotic prestress, than by contin-
uous expression of an inactive, active-site mutant.
Discussion
In this study we have used a method to conditionally regulate the
expression of TA systems and to obtain new insights into the role
of the ccd operon in persistence. Although we have specifically
applied this method to a prokaryotic TA system, it can be used for
any regulated system, including those within eukaryotic cells
wherein an inactive mutant of the protein can titrate a cellular
inhibitor. The present studies show that through appropriate point
mutations, it is possible to selectively modulate some binding/
catalytic functions without affecting others, even in compact,
single-domain globular proteins. In many cases it should be pos-
sible to set up appropriate genetic screens to isolate such mutants.
In a related approach, overexpression of a nontoxic mutant of
RelE was used to titrate endogenous RelB and thereby activate
endogenous RelE (5). In the relBE, mazEF and many other TA
systems the toxin component is enzymatically active. It is therefore
relatively straightforward to design mutations that lead to loss of
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Fig. 4. Role of CcdB in persister generation when present in multiple (A–C) or single copy (D–F). (A–C) Top10 strain containing either the multicopy plasmid
pccd (Top10pccd) or F-plasmid (Top10F′) or lacking any plasmid (Top10) were grown to an OD600 of 0.2–0.3. Subsequently, cells were exposed to different
prestresses, either a sublethal dose of ampicillin (1 μg/mL) for 1 h (A), heat at 48 °C for 20 min (B), or without any prestress (C). Subsequently, cultures were
exposed to different antibiotics at ∼10 times the minimal inhibitory concentration for 4 h, washed, and then plated on LB agar media for cfu/mL de-
termination. Survival ratio was calculated and is defined as the ratio of percent survival of the E. coli strain containing the ccd operon (either Top10pccd or
Top10F′) to that lacking the ccd operon (Top10) after antibiotic exposure. (D–F) A similar experiment was done in strains with the ccd operon integrated into
the chromosome. Normalized data for BWccd (containing ccd) E. coli strain with ampicillin (1 μg/mL) prestress (D), heat prestress (E), and without any prestress
(F) are shown. Normalization was done with respect to two different reference strains, BWcat (containing insertion of cat marker at the same locus as ccd)
and BW25113 (WT E. coli strain, lacking both cat and ccd), respectively. Error bars indicate the SE from three independent experiments.
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enzyme activity without significantly affecting antitoxin binding.
The CcdAB system is more challenging because CcdB has no
enzymatic activity. Furthermore, CcdB has significantly over-
lapping binding sites for CcdA and DNA gyrase and binds both
full-length proteins with KDs that are in the subnanomolar range
(22) (Fig. 1B). Despite this challenge, it was possible to isolate
CcdB mutants that abolish its Gyrase poisoning activity without
affecting CcdA binding (Fig. S2 and Table S1), even at residue
positions (such as 24I) that are involved in binding both proteins.
This is a surprising result, which demonstrates that it should be
possible to apply this methodology to many other TA systems, to
conditionally activate a single toxin in a background of multiple
other TA systems because of the specificity of TA interactions. A
recent study has shown that the ccdF system is able to mediate
postsegregational killing in an E. coli strain harboring the
ccdO157 system on its chromosome. This finding shows that the
plasmid ccdF system is functional even in the presence of its
chromosomal counterpart (23). Inhibitors of TA interactions can
be important leads for the development of new drugs in case of
TA systems that are involved in killing cells. The present study
validates the CcdAB system as a potential drug target because
complete titration of WT CcdA by an excess of inactive, active-site
mutants of CcdB results in cell death.
The factors responsible for generating bacterial persisters are
poorly understood. Transcriptional profiling of isolated per-
sisters indicated an overexpression of TA modules (24, 25). Al-
though the ectopic expression of several different toxins, such as
RelA, MazF, HipA, and YgiU resulted in increased persistence,
strains deleted for individual TA modules do not show decreased
persister formation until multiple TA modules are deleted (5). It
was previously known that the ccd operon is involved in plasmid
maintenance (8). In the present study, a putative role for the F-
plasmidic CcdAB TA system in persistence was elucidated. Ac-
tivation of endogenous CcdB either by CcdA titration or by
transient heat or antibiotic stress lead to measurably higher
amounts of persisters. Because the ccd operon occurs on the
transmissible F-plasmid, it is also an example of a transmissible
persistence factor. Homologs of F-plasmid ccd are also present
on the chromosome of pathogenic strains of E. coli (E. coli O157:
H7 str. EC4206, RefSeq accession no. ZP_03253116.1) and CcdB
homologs are present in other human pathogens, such as Shigella
dysenteriae (GenBank accession no. EGI89125.1) and Vibrio
cholera (RefSeq accession no. ZP_01978533). The sequence of
the chromosomal ccd systems have diverged significantly from
the F-plasmid ccd operon studied here, although in ∼70% of
cases both components of the chromosomal ccd have retained
their toxic activity (26). Molecular evolutionary analysis of 47
isolates of ccdB0157 suggested that the chromosomally encoded
ccdAB TA systems appear devoid of any biological function and
are under neutral evolution (26). Using approaches similar to the
ones described herein should clarify whether or not specific
chromosomally encoded ccd systems also contribute to persistence.
The present studies also suggest that, in addition to its known
role in antitoxin degradation (2, 5), the Lon protease has other
roles in the generation of persisters that need to be elucidated.
Like ciprofloxacin and other fluroquinolone antibiotics, CcdB
produces DNA lesions by stabilizing a cleaved DNA-gyrase
complex. This stabilization leads to induction of the RecA me-
diated SOS response. It is likely that this induction in turn leads
activation of other TA loci, the promoters of which contain a Lex
box. It has previously been shown that ciprofloxacin can induce
formation of persisters by SOS-mediated activation of the tisAB,
as well as other TA systems, which in turn may lead to dormancy
(17). A similar mechanism may hold for CcdB also and this is
outlined in Fig. 5. A stress that leads to elevated levels of Lon
will lead to release of CcdB from its complex with CcdA and the
resulting DNA lesion will result in an SOS response, ultimately
triggering conversion of cells to a dormant state.
Materials and Methods
E. coli host strains and plasmids used for this study are listed in Table S3. The
Top10 strain, which lacks the F-plasmid–encoded WT CcdA and CcdB, was used
to select inactive mutants of CcdB. XL1-Blue, Top10F′ and AB264 strains have
the F-plasmid that carries the ccd operon. All strains except AB264 are recA−.
BW25113 is a WT E. coli K12 strain that was used for chromosomal insertions of
the ccd operon and cat cassette. The ccdB gene was expressed under control of
the arabinose PBAD promoter in plasmid pBAD24ccdB. The CcdBmutants for the
study were taken from the library of CcdB mutants described previously (12).
The GyrA14 fragment (residues 363–494) (11), CcdA (27), and CcdB (28) were
expressed and purified in E. coli. Additional methodological details are given in
SI Materials and Methods.
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